Shareholders' Deficit

3 Months Ended

Mar. 31, 2024

Stockholders' Equity Note [Abstract]

Shareholders' Equity

Shareholders' Deficit

Under the authority of our Board of Directors, we repurchased shares of our Common Stock during the quarters ended March 31, 2024 and 2023 as indicated below.  All amounts exclude applicable transaction fees. 

	Shares Repurchased (thousands)		Dollar Value of Shares Repurchased				Remaining Dollar Value of Shares that may be Repurchased
Authorization Date	2024	2023	2024		2023		2024
September 2022	—	387	—		50		1,700
Total	—	387	$	—	$	50	$	1,700

In September 2022, our Board of Directors authorized share repurchases of up to $2 billion (excluding applicable transaction fees) of our outstanding Common Stock through June 30, 2024. As of March 31, 2024, we have remaining capacity to repurchase up to $1.7 billion of Common Stock under the September 2022 authorization.

Changes in Accumulated other comprehensive loss (“AOCI”) are presented below.

	Translation Adjustments and Gains (Losses) From Intra-Entity Transactions of a Long-Term Nature		Pension and Post-Retirement Benefits		Derivative Instruments		Total
Balance at December 31, 2023, net of tax	$	(201)	$	(104)	$	3	$	(302)
OCI, net of tax
Gains (losses) arising during the period classified into AOCI, net of tax	(10)		—		9		(1)
(Gains) losses reclassified from AOCI, net of tax	—		—		(6)		(6)
	(10)		—		3		(7)
Balance at March 31, 2024, net of tax	$	(211)	$	(104)	$	6	$	(309)